Shi‐Cang Yu
- Molecular Biology top 2%
- Oncology top 1%
- Cancer Research top 1%
- Immunology top 2%
- Genetics top 2%
- Topics
- Cancer Cells and Metastasis (24 papers)Cancer, Hypoxia, and Metabolism (16 papers)Glioma Diagnosis and Treatment (12 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shi‐Cang Yu
73 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.6k
- Oncology 2.1k
- Cancer Research 1.6k
- Immunology 1.1k
- Genetics 592
Countries citing papers authored by Shi‐Cang Yu
This map shows the geographic impact of Shi‐Cang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Cang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Cang Yu more than expected).
Fields of papers citing papers by Shi‐Cang Yu
This network shows the impact of papers produced by Shi‐Cang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Cang Yu. The network helps show where Shi‐Cang Yu may publish in the future.
Co-authorship network of co-authors of Shi‐Cang Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Cang Yu. A scholar is included among the top collaborators of Shi‐Cang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Cang Yu. Shi‐Cang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 40 | |
| 8 | 19 | |
| 9 | 33 | |
| 10 | 174 | |
| 11 | 88 | |
| 12 | 79 | |
| 13 | 75 | |
| 14 | 85 | |
| 15 | 30 | |
| 16 | 15 | |
| 17 | 204 | |
| 18 | 51 | |
| 19 | 7 | |
| 20 | Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model. | 14 |
About Shi‐Cang Yu
Shi‐Cang Yu is a scholar working on Cancer Research, Structural Biology and Genetics, having authored 77 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (24 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Glioma Diagnosis and Treatment (12 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.1k citations) and Genetics (592 citations). Shi‐Cang Yu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Li Yin, Xiu‐Wu Bian, Yi‐Fang Ping, You‐Hong Cui, Xian-Zong Ye, Senlin Xu, Cheng Qian, Yi Liang, Jiang‐Jie Duan and Lei Gao. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.